Literature DB >> 22392126

Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases.

Kazuhiro Ohtakara1, Shinya Hayashi, Noriyuki Nakayama, Naoyuki Ohe, Hirohito Yano, Toru Iwama, Hiroaki Hoshi.   

Abstract

The objective of this study was to investigate the factors that potentially lead to brain radionecrosis (RN) after micromultileaf collimator-based stereotactic radiosurgery (SRS) for brain metastases. We retrospectively evaluated 131 lesions with a minimum follow-up of 6 months, 43.5% of which received prior whole-brain radiotherapy (WBRT). The three-tiered location grade (LG) was defined, as follows, for each target by considering mainly the depth from the brain surface: grade 1 (superficial), involving the region at a depth of ≤5 mm from the brain surface; grade 2 (deep), located at a depth of >5 mm from the brain surface; and grade 3 (central), located in the brainstem, cerebellar peduncle, diencephalon, or basal ganglion. The predictive factors for RN, including high-dose irradiated isodose volumes (IIDVs) and LG, were evaluated by univariate and multivariate analysis. Symptomatic RN (S-RN) and asymptomatic RN (A-RN) were observed in 8.4% and 6.9% of cases, respectively. Multivariate analysis indicated that the significant factors for both types of RN were LG, V12 Gy, and V22 Gy in all cases; V22 Gy and LG for the non-WBRT cases; and V15 Gy and LG for the WBRT cases. For the non-WBRT cases, the cutoff values of V22 Gy were 2.62 and 2.14 cm(3) for S-RN and both RN, respectively. For the WBRT cases, the cutoff values of V15 Gy were 5.61 and 5.20 cm(3) for S-RN and both RN, respectively. In addition to the IIDV data, LG helps predict the risk of RN. High-dose IIDV, V22 Gy, was also significantly correlated with RN, particularly for patients treated with SRS alone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22392126     DOI: 10.1007/s11060-012-0834-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  32 in total

1.  Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity.

Authors:  Antje Ernst-Stecken; Oliver Ganslandt; Ulrike Lambrecht; Rolf Sauer; Gerhard Grabenbauer
Journal:  Radiother Oncol       Date:  2006-09-15       Impact factor: 6.280

2.  Characterisation of dose distribution in linear accelerator-based intracranial stereotactic radiosurgery with the dynamic conformal arc technique: consideration of the optimal method for dose prescription and evaluation.

Authors:  K Ohtakara; S Hayashi; H Hoshi
Journal:  Br J Radiol       Date:  2011-02-22       Impact factor: 3.039

3.  T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery.

Authors:  Hideyuki Kano; Douglas Kondziolka; Javier Lobato-Polo; Oscar Zorro; John C Flickinger; L Dade Lunsford
Journal:  Neurosurgery       Date:  2010-03       Impact factor: 4.654

4.  Risk analysis of linear accelerator radiosurgery.

Authors:  J Voges; H Treuer; V Sturm; C Büchner; R Lehrke; M Kocher; S Staar; J Kuchta; R P Müller
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-12-01       Impact factor: 7.038

5.  Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up.

Authors:  L S Chin; L Ma; S DiBiase
Journal:  J Neurosurg       Date:  2001-06       Impact factor: 5.115

6.  Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence.

Authors:  Chiaki Asao; Yukunori Korogi; Mika Kitajima; Toshinori Hirai; Yuji Baba; Keishi Makino; Masato Kochi; Shoji Morishita; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

7.  Factors influencing the risk for complications following Gamma Knife radiosurgery of cerebral arteriovenous malformations.

Authors:  B Karlsson; I Lax; M Söderman
Journal:  Radiother Oncol       Date:  1997-06       Impact factor: 6.280

8.  Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.

Authors:  Brian J Blonigen; Ryan D Steinmetz; Linda Levin; Michael A Lamba; Ronald E Warnick; John C Breneman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-23       Impact factor: 7.038

9.  Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.

Authors:  Giuseppe Minniti; Enrico Clarke; Gaetano Lanzetta; Mattia Falchetto Osti; Guido Trasimeni; Alessandro Bozzao; Andrea Romano; Riccardo Maurizi Enrici
Journal:  Radiat Oncol       Date:  2011-05-15       Impact factor: 3.481

Review 10.  The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.

Authors:  Mark E Linskey; David W Andrews; Anthony L Asher; Stuart H Burri; Douglas Kondziolka; Paula D Robinson; Mario Ammirati; Charles S Cobbs; Laurie E Gaspar; Jay S Loeffler; Michael McDermott; Minesh P Mehta; Tom Mikkelsen; Jeffrey J Olson; Nina A Paleologos; Roy A Patchell; Timothy C Ryken; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2009-12-04       Impact factor: 4.130

View more
  14 in total

1.  Cerebral cyst formation following stereotactic ablative irradiation for non-nasopharyngeal head and neck malignancies: imaging findings and relevant dosimetric parameters.

Authors:  K Ohtakara; H Hoshi
Journal:  Br J Radiol       Date:  2014-02-26       Impact factor: 3.039

2.  Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy.

Authors:  Kim Kramer; Neeta Pandit-Taskar; Pat Zanzonico; Suzanne L Wolden; John L Humm; Carl DeSelm; Mark M Souweidane; Jason S Lewis; Nai-Kong V Cheung
Journal:  J Neurooncol       Date:  2015-05-06       Impact factor: 4.130

3.  The Incidence and Its Associated Factors Relevant to Brain Radionecrosis That Requires Intervention Following Single or Fractionated Stereotactic Radiosurgery Using Vero4DRT for Brain Metastases.

Authors:  Takehiro Yamada; Kazuhiro Ohtakara; Takeshi Kamomae; Junji Itoh; Hideki Shimada; Shunichi Ishihara; Shinji Naganawa
Journal:  Cureus       Date:  2022-06-13

4.  Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease.

Authors:  Stefano Telera; Alessandra Fabi; Andrea Pace; Antonello Vidiri; Vincenzo Anelli; Carmine Maria Carapella; Laura Marucci; Francesco Crispo; Isabella Sperduti; Alfredo Pompili
Journal:  J Neurooncol       Date:  2013-03-25       Impact factor: 4.130

5.  Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases.

Authors:  Zachary A Kohutek; Yoshiya Yamada; Timothy A Chan; Cameron W Brennan; Viviane Tabar; Philip H Gutin; T Jonathan Yang; Marc K Rosenblum; Åse Ballangrud; Robert J Young; Zhigang Zhang; Kathryn Beal
Journal:  J Neurooncol       Date:  2015-08-26       Impact factor: 4.130

6.  Resection cavity radiosurgery for intracranial metastases: a review of the literature.

Authors:  Ying Zhang; Eric L Chang
Journal:  J Radiosurg SBRT       Date:  2014

Review 7.  Does Stereotactic Radiosurgery Have a Role in the Management of Patients Presenting With 4 or More Brain Metastases?

Authors:  Michael H Soike; Ryan T Hughes; Michael Farris; Emory R McTyre; Christina K Cramer; J D Bourland; Michael D Chan
Journal:  Neurosurgery       Date:  2019-03-01       Impact factor: 5.315

Review 8.  Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.

Authors:  Michael T Milano; Jimm Grimm; Andrzej Niemierko; Scott G Soltys; Vitali Moiseenko; Kristin J Redmond; Ellen Yorke; Arjun Sahgal; Jinyu Xue; Anand Mahadevan; Alexander Muacevic; Lawrence B Marks; Lawrence R Kleinberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-09-11       Impact factor: 8.013

9.  Institutional experience with SRS VMAT planning for multiple cranial metastases.

Authors:  Åse Ballangrud; Li Cheng Kuo; Laura Happersett; Seng Boh Lim; Kathryn Beal; Yoshiya Yamada; Margie Hunt; James Mechalakos
Journal:  J Appl Clin Med Phys       Date:  2018-02-23       Impact factor: 2.102

10.  The potential of an optical surface tracking system in non-coplanar single isocenter treatments of multiple brain metastases.

Authors:  Ans C C Swinnen; Michel C Öllers; Chin Loon Ong; Frank Verhaegen
Journal:  J Appl Clin Med Phys       Date:  2020-04-01       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.